165 related articles for article (PubMed ID: 21731466)
21. Effect of supercritical fluid density on nanoencapsulated drug particle size using the supercritical antisolvent method.
Kalani M; Yunus R
Int J Nanomedicine; 2012; 7():2165-72. PubMed ID: 22619552
[TBL] [Abstract][Full Text] [Related]
22. Supercritical antisolvent co-precipitation of rifampicin and ethyl cellulose.
Djerafi R; Swanepoel A; Crampon C; Kalombo L; Labuschagne P; Badens E; Masmoudi Y
Eur J Pharm Sci; 2017 May; 102():161-171. PubMed ID: 28302396
[TBL] [Abstract][Full Text] [Related]
23. Supercritical antisolvent precipitation of PHBV microparticles.
Costa MS; Duarte AR; Cardoso MM; Duarte CM
Int J Pharm; 2007 Jan; 328(1):72-7. PubMed ID: 16971075
[TBL] [Abstract][Full Text] [Related]
24. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
[TBL] [Abstract][Full Text] [Related]
25. Modified supercritical antisolvent method with enhanced mass transfer to fabricate drug nanoparticles.
Kakran M; Sahoo NG; Antipina MN; Li L
Mater Sci Eng C Mater Biol Appl; 2013 Jul; 33(5):2864-70. PubMed ID: 23623107
[TBL] [Abstract][Full Text] [Related]
26. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
Park J; Park HJ; Cho W; Cha KH; Kang YS; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):239-45. PubMed ID: 20599602
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation.
Zu Y; Sun W; Zhao X; Wang W; Li Y; Ge Y; Liu Y; Wang K
Eur J Pharm Sci; 2014 Mar; 53():109-17. PubMed ID: 24345795
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of wettability and dissolution properties of cilostazol using the supercritical antisolvent process: effect of various additives.
Kim MS; Kim JS; Hwang SJ
Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):230-3. PubMed ID: 20118585
[TBL] [Abstract][Full Text] [Related]
29. Insulin nanoparticles for transdermal delivery: preparation and physicochemical characterization and in vitro evaluation.
Zhao X; Zu Y; Zu S; Wang D; Zhang Y; Zu B
Drug Dev Ind Pharm; 2010 Oct; 36(10):1177-85. PubMed ID: 20367030
[TBL] [Abstract][Full Text] [Related]
30. Experimental investigation and oral bioavailability enhancement of nano-sized curcumin by using supercritical anti-solvent process.
Anwar M; Ahmad I; Warsi MH; Mohapatra S; Ahmad N; Akhter S; Ali A; Ahmad FJ
Eur J Pharm Biopharm; 2015 Oct; 96():162-72. PubMed ID: 26241925
[TBL] [Abstract][Full Text] [Related]
31. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
[TBL] [Abstract][Full Text] [Related]
32. Improving stability and oral bioavailability of hydroxycamptothecin via nanocrystals in microparticles (NCs/MPs) technology.
Wang Y; Xuan J; Zhao G; Wang D; Ying N; Zhuang J
Int J Pharm; 2021 Jul; 604():120729. PubMed ID: 34029666
[TBL] [Abstract][Full Text] [Related]
33. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect.
Wang A; Li S
BMC Biotechnol; 2008 May; 8():46. PubMed ID: 18454874
[TBL] [Abstract][Full Text] [Related]
34. Thermal behavior and thermal decarboxylation of 10-hydroxycamptothecin in the solid state.
Wang SL; Lin SY; Hsieh TF; Chan SA
J Pharm Biomed Anal; 2007 Jan; 43(2):457-63. PubMed ID: 16934429
[TBL] [Abstract][Full Text] [Related]
35. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.
Yang X; Liu Y; Zhao Y; Han M; Guo Y; Kuang H; Wang X
Int J Nanomedicine; 2016; 11():2979-94. PubMed ID: 27382284
[TBL] [Abstract][Full Text] [Related]
36. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
[TBL] [Abstract][Full Text] [Related]
37. Supercritical fluid assisted atomization introduced by an enhanced mixer for micronization of lysozyme: Particle morphology, size and protein stability.
Du Z; Guan YX; Yao SJ; Zhu ZQ
Int J Pharm; 2011 Dec; 421(2):258-68. PubMed ID: 22001535
[TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of 10-hydroxycamptothecin loaded nanostructured lipid carriers.
Liu K; Sun J; Wang Y; He Y; Gao K; He Z
Drug Dev Ind Pharm; 2008 May; 34(5):465-71. PubMed ID: 18473227
[TBL] [Abstract][Full Text] [Related]
39. Physicochemical properties and oral bioavailability of ursolic acid nanoparticles using supercritical anti-solvent (SAS) process.
Yang L; Sun Z; Zu Y; Zhao C; Sun X; Zhang Z; Zhang L
Food Chem; 2012 May; 132(1):319-25. PubMed ID: 26434296
[TBL] [Abstract][Full Text] [Related]
40. Production of pure indinavir free base nanoparticles by a supercritical anti-solvent (SAS) method.
Imperiale JC; Bevilacqua G; Rosa Pde T; Sosnik A
Drug Dev Ind Pharm; 2014 Dec; 40(12):1607-15. PubMed ID: 24050705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
